Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Content Filter
Choose a Topic
ADC
Agreement
Appointment
Big Data
Biologics
Biomanufacturing
Biosimilars
Business
Capacity Expansion
CDMO
Cell and Gene Therapy
Clinical Trials
Collaboration
Continuous Manufacturing
CRISPR
CRO
DNA
Drug Delivery
Drug Development
Drug Discovery
Drug Substance
Engineering
Equipment
Excipients
Facility
Formulation
Generics
Growth
Healthcare
Immunotherapy
Innovation
Investment
Licensing
Logistics
Manufacturing
Market Expansion
Market Intelligence
Market Prediction
Next Generation Therapies
Novel Therapeutics
Oncology
Oral Solid Dosage
Orphan Drugs
Packaging
Parenterals
Patient Adherence
Patient Centric
Preclinical
Process Development
Regulatory
Research
Serialization
Stem Cells
Strategic Partnership
Supply Chain
Vaccine
Intermediates
×
Choose a Section
Features
News
Press Releases
Roundtable
In Conversation
Nice Consulting
Virtual Panel
Trends Trending
×
Choose an Issue
Issue Q3 2019
Issue Q2 2019
Issue Q1 2019
Issue Q4 2018
Issue Q3 2018
Issue Q2 2018
Issue Q1 2018
Issue Q4 2017
Issue Q3 2017
Issue Q2 2017
Issue Q1 2017
Issue Q4 2016
Issue Q3 2016
Issue Q2 2016
Issue Q1 2016
Issue Q4 2015
×
3921 Articles Available
1
164
Can't find what you're looking for? Try our
advanced search
.
Restructuring
Halozyme Announces Actions To Focus Strategy On ENHANZE® Drug Delivery Technology
PR-M11-19-NI-009
HIV-1
FDA Authorizes Marketing of First Next-Generation Sequencing Test for Detecting HIV-1 Drug Resistance Mutations
PR-M11-19-NI-008
M&A
Stryker Announces Definitive Agreement to Acquire Wright Medical
PR-M11-19-NI-007
FDA Approval
Sandoz Receives FDA Approval for Oncology Supportive Care Biosimilar Ziextenzo™
PR-M11-19-NI-006
FDA
The FDA Warns that Biotin May Interfere with Lab Tests
PR-M11-19-NI-005
Funding
Startup Gets Significant Funding to Support Novel Biosensing Technology
PAO-M11-19-NI-004
FDA
Trump Nominates FDA Commissioner – and It Isn’t Sharpless
PAO-M11-19-NI-003
Drug Pricing
New Bill Proposes to Lower Drug Costs
PAO-M11-19-NI-002
RNA
RNA Repressor Switches Off Protein Production
PAO-M11-19-NI-001
Partner
Revolution Medicines and Amgen Partner on Phase 1b Study to Evaluate Combination of RMC-4630 and AMG 510
PR-M11-19-NI-004
FDA
Compugen Announces FDA Clearance of IND Application for COM902
PR-M11-19-NI-003
Clinical Trials
Ichnos Sciences Announces Completion of Enrollment of Phase 2b Trials for Two Investigational Therapies - ISB 830 and ISC 27864
PR-M11-19-NI-002
Funding
T3D Therapeutics Closes $15M Financing to Advance Phase 2 Development of T3D-959 in a New Approach to Treating Alzheimer's Disease
PR-M11-19-NI-001
Investment in Innovation
Should You Choose a Commercial HPAPI Manufacturer for Your Clinical Program?
PAO-11-2019-CL-001
Endpoints
Sanifit Announces the Phase 2b CaLIPSO Trial of SNF472 Met Endpoint in Slowing the Cardiovascular Calcification in Patients on Hemodialysis
PR-M10-19-NI-051
Commercial Agreement
Dicerna™ Enters Agreement with Roche to Develop and Commercialize DCR-HBVS for the Treatment of Chronic Hepatitis B Virus (HBV) Infection
PR-M10-19-NI-050
Launch
ANI Pharmaceuticals Announces the Launch of ANI Global Source, its Contract Development and Manufacturing Business
PR-M10-19-NI-049
Strategic Collaboration
Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China
PR-M10-19-NI-048
Recall
FDA Updates and Press Announcements on NDMA in Zantac (ranitidine)
PR-M10-19-NI-047
License Agreement
SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor
PR-M10-19-NI-046
AI
Vetter Provides Greater Flexibility in Secondary Packaging Through Collaborative Work
PR-M10-19-NI-045
Funding
Arranta Bio Announces $82M in New Funding, and a Strategic Partnership with Thermo Fisher Scientific
PR-M10-19-NI-044
Orphan Drugs
Customer Engagement and Information Sharing are Essential for Success in Orphan Drug Outsourcing
PAP-Q3-19-CL-013
Clinical Results
TG Therapeutics Announces Positive Results from the UNITY-NHL Phase 2b Pivotal Trial Evaluating Umbralisib Monotherapy in Patients with Relapsed/Refractory Follicular Lymphoma
PR-M10-19-NI-042
1
164
»
